MTZ Clinical Research

Warsaw 02106

0 studies enrolling now · 3 studies all time

What they study most

Hemophilia B, Refractory B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma, Solid Tumor

Studies at this site

• Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial) — Stopped early
• Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B — Completed
• Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL — Stopped early